PCRX : Insider Transactions for Pacira Pharmaceuticals, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Pacira Pharmaceuticals, Inc. (PCRX)

$30.82

0.44 (1.45%) as of 4:30 Tue 5/14

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

49,450,000

Market Cap:

1.52(B)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$25.5 - $42.47

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Drug Manufacturers - Major

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 623

Guru Rank Value : 3

Guru Occurances : 1


6 Months 1 Year 2 Year

Company Profile Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	119,323	119,323	189,781	290,198
Total Sell Value	$3,656,226	$3,656,226	$6,334,261	$12,063,571
Total People Sold	1	1	15	16
Total Sell Transactions	3	3	34	58
End Date	2024-02-15	2023-11-14	2023-05-16	2022-05-16

Adjust Filter Settings

Records found: 781

Page 15 of 32

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

CEO and Chairman

• • –

2019-06-04

4

S

$42.91

$531,440

D/D

(12,385)

121,531

-

Riker Lauren Bullaro

Vice President, Finance

• – –

2019-06-04

4

S

$42.91

$41,494

D/D

(967)

10,268

-

Scranton Richard

Chief Scientific Officer

• – –

2019-06-03

4

AS

$43.21

$670,187

D/D

(15,510)

20,101

-

Scranton Richard

Chief Scientific Officer

• – –

2019-06-03

4

OE

$10.52

$166,790

D/D

15,510

35,611

-

Kronenfeld Mark A.

Director

– • –

2019-03-06

4

B

$38.72

$66,244

D/D

1,700

10,277

2.39

-

CEO and Chairman

• • –

2018-12-18

4

OE

$1.61

$42,600

D/D

12,000

133,683

-

Director

– • –

2018-12-13

4

S

$46.18

$402,692

I/I

(8,720)

950,362

-

Director

– • –

2018-12-12

4

S

$47.84

$277,803

I/I

(5,807)

959,082

-

Director

– • –

2018-11-19

4

S

$47.08

$46,605

I/I

(990)

964,889

-

Director

– • –

2018-11-19

4

B

$46.18

$207,810

D/D

4,500

32,819

2.39

-

Director

– • –

2018-11-16

4

S

$46.79

$1,198,775

I/I

(25,600)

965,879

-

Director

– • –

2018-11-15

4

S

$47.63

$2,138,811

I/I

(44,898)

991,479

-

CEO and Chairman

• • –

2018-11-15

4

AS

$47.25

$710,801

D/D

(15,000)

121,683

-

Director

– • –

2018-11-12

4

S

$49.83

$272,980

I/I

(5,478)

1,036,377

-

Director

– • –

2018-11-09

4

S

$50.23

$45,508

I/I

(906)

1,041,855

-

Director

– • –

2018-11-08

4

S

$51.13

$2,931,583

I/I

(57,339)

1,042,761

-

Director

– • –

2018-11-07

4

B

$51.29

$205,160

D/D

4,000

28,319

2.39

-

Riker Lauren Bullaro

Vice President, Finance

• – –

2018-11-02

4

AS

$54.35

$54,350

D/D

(1,000)

10,474

-

Riker Lauren Bullaro

Vice President, Finance

• – –

2018-11-02

4

OE

$10.34

$10,340

D/D

1,000

11,474

-

CEO and Chairman

• • –

2018-10-11

4

OE

$1.61

$130,650

D/D

45,000

136,683

-

Riker Lauren Bullaro

Vice President, Finance

• – –

2018-09-24

4

AS

$50.70

$50,700

D/D

(1,000)

10,474

-

Riker Lauren Bullaro

Vice President, Finance

• – –

2018-09-24

4

OE

$10.34

$10,340

D/D

1,000

11,474

-

Kronenfeld Mark A.

Director

– • –

2018-08-28

4

B

$44.61

$44,611

D/D

1,000

8,577

2.39

-

Riker Lauren Bullaro

Vice President, Finance

• – –

2018-08-22

4

S

$44.48

$74,148

D/D

(1,667)

10,474

-

CEO and Chairman

• • –

2018-08-15

4

AS

$47.11

$1,564,432

D/D

(33,062)

91,683

-

781 Records found	Previous 10 11 12 13 14 15 16 17 18 19 Next	Page 15 of 32

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.